Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing Co

Biocon Ltd has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialise its GLP-1 products for diabetes and chronic weight management in select Middle Eastern countries. Tabuk Pharmaceuticals will handle marketing, registration, import, and promotion. The agreement includes potential expansion to other GLP products and localised manufacturing.